Clinically, linc-POU3F3 expression correlates with adverse outcomes in CRC, such as an increased risk of recurrence and reduced recurrence-free survival, indicating that linc-POU3F3-mediated autophagy inhibition may exacerbate the malignant characteristics of CRC [150]. This evidence concerns the gene PANTR1 and colorectal carcinoma.